Skip to content
★ Sign in to follow
메디

메디앙스 Stock: price and insider trades · South Korea

KR·Mcap ₩18.4BRetail

No insider purchase over the last 90 days. The latest, by 김은정, was filed 30 Jun 2026.

메디앙스: what insiders have been doing

메디앙스 is a Retail company. Its directors and officers file their transactions with DART (FSS). In the past year (1 November 2025 to 1 November 2026), 5 filings came from 2 insiders.

No insider sold shares on the market over the period. Instead, the filings list 4 purchases, made by 1 insider. The totals exclude 4 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 1 major shareholder.

The last insider purchase was made public on 30 June 2026, 133 days ago.

With 5 filings in twelve months, the company is quieter than the median of 7 filings across the 2,655 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 7 purchases and no sales.

In the same sector, recent insider purchases at Rusta AB (publ) and Harvia Oyj also feature in our signals. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Insider Decl.
12
Thresholds
n/a
Buy Volume
€1M
7 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
김은정4 buys
Fundamental score
Ranked 23,615 of 26,911 companies
24.1
score / 100
Value
11
Quality
37
FCF yld-12%
Earn yld-34%
EV/EBITDA·
ROE-0.8%
Gross mgn49%
Net mgn-12%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩1,630
Analyst consensus
·
Income statement
Revenue₩48.8B
Gross profit₩23.8B49% margin
EBITDA-₩3.8B-8% margin
Net income-₩6B-1.1% margin
Valuation
Beta0.14
Balance sheet & cash
Market cap₩18.4B
Total debt₩16.9B
Free Cash Flow-₩2.2B
Debt / Equity25%
Profitability & ownership
ROE-0.8%
ROA-1.0%
% insiders38.1%
% institutions0.0%
Last declaration on 30 June 2026
Declarations13 total
  • Other
    Other(filed)
    0DART
  • ▲
    대량보유자Executives(filed)
    €34kest.0DART
    35,079 sharesKRXDART:20260630001089
    Canonical exit: 28 Sept 2026 (T+90)
  • ▲
    대량보유자Executives(filed)
    €55kest.0DART
    57,439 sharesKRXDART:20260622000405
    Canonical exit: 20 Sept 2026 (T+90)
  • ▲
    대량보유자Executives(filed)
    €35kest.0DART
    37,996 sharesKRXDART:20260615000437
    Canonical exit: 13 Sept 2026 (T+90)
  • ▲
    대량보유자Executives
    €237kest.0DART
    270,016 sharesKRXDART:20260529001822
    Canonical exit: 26 Aug 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives
    €338kest.0DART
    154,832 sharesKRXDART:20230711000338
    Canonical exit: 3 Oct 2023 (T+90)
  • ▲
    Executives
    €393kest.0DART
    180,750 sharesKRXDART:20230601000431
    Canonical exit: 16 Aug 2023 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    Executives(filed)
    €146kest.0DART
    44,285 sharesKRXDART:20220613000357
    Canonical exit: 12 Sept 2022 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART

13 of 13 declarations

About 메디앙스

Mediance is a company operating in the distribution and commerce sector, listed on the XKRX.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations